Raymond James Financial Services Advisors’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.1M Buy
434,856
+176,667
+68% +$3.29M 0.01% 970
2024
Q2
$4.51M Buy
258,189
+16,144
+7% +$270K 0.01% 1224
2024
Q1
$4.08M Sell
242,045
-10,926
-4% -$186K 0.01% 1250
2023
Q4
$4.19M Buy
252,971
+13,816
+6% +$212K 0.01% 1179
2023
Q3
$3.72M Sell
239,155
-7,878
-3% -$131K 0.01% 1171
2023
Q2
$4.21M Buy
247,033
+8,757
+4% +$152K 0.01% 1113
2023
Q1
$4.21M Buy
238,276
+228
+0.1% +$4.15K 0.01% 1082
2022
Q4
$4.29M Sell
238,048
-49,929
-17% -$925K 0.01% 1046
2022
Q3
$4.98M Sell
287,977
-60,435
-17% -$1.16M 0.01% 916
2022
Q2
$6.51M Buy
348,412
+3,796
+1% +$75.1K 0.01% 809
2022
Q1
$7.16M Buy
344,616
+15,069
+5% +$320K 0.01% 829
2021
Q4
$7.83M Buy
329,547
+7,166
+2% +$179K 0.01% 791
2021
Q3
$8.24M Sell
322,381
-820
-0.3% -$21.6K 0.02% 752
2021
Q2
$8.32M Sell
323,201
-2,015
-0.6% -$49.7K 0.02% 743
2021
Q1
$7.94M Sell
325,216
-1,050
-0.3% -$25.6K 0.02% 713
2020
Q4
$7.78M Sell
326,266
-33,251
-9% -$722K 0.02% 659
2020
Q3
$7.41M Buy
359,517
+27,884
+8% +$589K 0.02% 605
2020
Q2
$7.07M Buy
331,633
+40,346
+14% +$822K 0.02% 582
2020
Q1
$5.19M Sell
291,287
-2,899
-1% -$57.2K 0.02% 535
2019
Q4
$6.14M Sell
294,186
-2,462
-0.8% -$48.8K 0.02% 661
2019
Q3
$5.44M Buy
296,648
+18,104
+6% +$349K 0.02% 668
2019
Q2
$5.59M Buy
278,544
+20,150
+8% +$398K 0.02% 640
2019
Q1
$5.31M Buy
+258,394
New +$5.29M 0.02% 633
2018
Q4
Sell
-204,825
Closed -$4.74M 2664
2018
Q3
$4.74M Buy
204,825
+14,196
+7% +$321K 0.02% 675
2018
Q2
$4.1M Buy
190,629
+15,065
+9% +$321K 0.02% 683
2018
Q1
$3.78M Buy
175,564
+80,329
+84% +$1.85M 0.02% 664
2017
Q4
$2.15M Buy
95,235
+56,330
+145% +$1.32M 0.01% 887
2017
Q3
$982K Sell
38,905
-1,251
-3% -$31.4K 0.01% 1314
2017
Q2
$1.01M Sell
40,156
-6,364
-14% -$158K 0.01% 1260
2017
Q1
$1.12M Sell
46,520
-1,859
-4% -$43.6K 0.01% 1110
2016
Q4
$1.02M Sell
48,379
-4,922
-9% -$110K 0.01% 1103
2016
Q3
$1.27M Sell
53,301
-2,839
-5% -$71.4K 0.01% 972
2016
Q2
$1.32M Buy
56,140
+4,733
+9% +$117K 0.01% 910
2016
Q1
$1.23M Buy
51,407
+2,246
+5% +$53.4K 0.01% 812
2015
Q4
$1.46M Buy
49,161
+35,577
+262% +$1.1M 0.02% 770
2015
Q3
$375K Buy
+13,584
New +$462K 0.01% 1166
2014
Q1
Sell
-22,572
Closed -$595K 527
2013
Q4
$595K Buy
22,572
+152
+0.7% +$3.72K 0.04% 398
2013
Q3
$526K Sell
22,420
-53,150
-70% -$1.26M 0.03% 396
2013
Q2
$1.7M Buy
+75,570
New +$1.61M 0.05% 437

Other funds holding HQH

Raymond James Financial Services Advisors's HQH Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its abrdn Healthcare Investors (HQH) stake by 68% in Q3 2024, buying an estimated $3.29M and bringing the position to 434,856 shares worth $8.1M. The position accounts for 0.01% of the portfolio, ranked #970.

Raymond James Financial Services Advisors first reported a position in HQH in Q2 2013 and has held it in 39 quarters since. The position peaked at $8.32M in Q2 2021. 122 funds tracked by Wall St. Rank hold HQH as of Q3 2024.

  • Raymond James Financial Services Advisors held 434,856 shares of abrdn Healthcare Investors worth $8.1M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 176,667 abrdn Healthcare Investors shares in Q3 2024, an estimated $3.29M.
  • abrdn Healthcare Investors made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #970 holding.
  • Raymond James Financial Services Advisors first reported a position in abrdn Healthcare Investors in Q2 2013 and has held it in 39 quarters since.
  • Raymond James Financial Services Advisors's abrdn Healthcare Investors position peaked at $8.32M in Q2 2021.
  • 122 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.